Cargando…

Role of the Beta Catenin Destruction Complex in Mediating Chemotherapy-Induced Senescence-Associated Secretory Phenotype

Cellular senescence is considered as a tumor suppressive mechanism. Recent evidence indicates however that senescent cells secrete various growth factors and cytokines, some of which may paradoxically promote cancer progression. This phenomenon termed senescence-associated secretory phenotype (SASP)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basu, Dipanjan, Reyes-Mugica, Miguel, Rebbaa, Abdelhadi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525570/ https://www.ncbi.nlm.nih.gov/pubmed/23272224 http://dx.doi.org/10.1371/journal.pone.0052188

Ejemplares similares

Histone Acetylation-Mediated Regulation of the Hippo Pathway
por: Basu, Dipanjan, et al.
Publicado: (2013)

The destruction complex of beta-catenin in colorectal carcinoma and colonic adenoma
por: Bourroul, Guilherme Muniz, et al.
Publicado: (2016)

Cell senescence, the senescence-associated secretory phenotype, and cancers
por: Langhi Prata, Larissa G. P., et al.
Publicado: (2023)

Exosomes as Emerging Pro-Tumorigenic Mediators of the Senescence-Associated Secretory Phenotype
por: Jakhar, Rekha, et al.
Publicado: (2019)

Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease
por: Wang, Wen-Juan, et al.
Publicado: (2017)

MLL1 is essential for the senescence-associated secretory phenotype
por: Capell, Brian C., et al.
Publicado: (2016)

The Role of Senescence-Associated Secretory Phenotype in Bone Loss
por: Zhu, Runjiu, et al.
Publicado: (2022)

The senescence-associated secretory phenotype induces neuroendocrine transdifferentiation
por: Huna, Anda, et al.
Publicado: (2023)

Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
por: Kumari, Ruchi, et al.
Publicado: (2021)

Overcoming the senescence‐associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer
por: Chambers, Cecilia R., et al.
Publicado: (2021)

Senescence-activated enhancer landscape orchestrates the senescence-associated secretory phenotype in murine fibroblasts
por: Guan, Yiting, et al.
Publicado: (2020)

Immunotherapeutic approach to reduce senescent cells and alleviate senescence‐associated secretory phenotype in mice
por: Shrestha, Niraj, et al.
Publicado: (2023)

In vitro and in vivo effects of zoledronic acid on senescence and senescence-associated secretory phenotype markers
por: Samakkarnthai, Parinya, et al.
Publicado: (2023)

NF90 coordinately represses the senescence-associated secretory phenotype
por: Tominaga-Yamanaka, Kumiko, et al.
Publicado: (2012)

HMGB2 holds the key to the senescence-associated secretory phenotype
por: Guerrero, Ana, et al.
Publicado: (2016)

Suppression of p16 alleviates the senescence-associated secretory phenotype
por: Buj, Raquel, et al.
Publicado: (2021)

Expression profile of components of the β-catenin destruction complex in oral dysplasia and oral cancer
por: Goñi, Francisca J, et al.
Publicado: (2021)

A model of the onset of the senescence associated secretory phenotype after DNA damage induced senescence
por: Meyer, Patrick, et al.
Publicado: (2017)

IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma
por: Homann, Lorenzo, et al.
Publicado: (2022)

Ceria Nanoparticles Alleviated Osteoarthritis through Attenuating Senescence and Senescence-Associated Secretory Phenotype in Synoviocytes
por: Ren, Xunshan, et al.
Publicado: (2023)

Colchicine Protects against Ethanol-Induced Senescence and Senescence-Associated Secretory Phenotype in Endothelial Cells
por: Zhou, Huakang, et al.
Publicado: (2023)

The senescence-associated secretory phenotype induces cellular plasticity and tissue regeneration
por: Ritschka, Birgit, et al.
Publicado: (2017)

Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma
por: Lee, Jee San, et al.
Publicado: (2017)

The bright and dark side of extracellular vesicles in the senescence-associated secretory phenotype
por: Wallis, Ryan, et al.
Publicado: (2020)

Extracellular Nicotinamide Phosphoribosyltransferase Is a Component of the Senescence-Associated Secretory Phenotype
por: Kuehnemann, Chisaka, et al.
Publicado: (2022)

Senescence-associated secretory phenotype and its impact on oral immune homeostasis
por: Yue, Ziqi, et al.
Publicado: (2022)

Molecular regulation and pharmacological targeting of the β‐catenin destruction complex
por: van Kappel, Eline C, et al.
Publicado: (2017)

Phase separation of Axin organizes the β-catenin destruction complex
por: Nong, Junxiu, et al.
Publicado: (2021)

Supramolecular assembly of the beta-catenin destruction complex and the effect of Wnt signaling on its localization, molecular size, and activity in vivo
por: Schaefer, Kristina N., et al.
Publicado: (2018)

Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor
Publicado: (1994)

From cell senescence to age-related diseases: differential mechanisms of action of senescence-associated secretory phenotypes
por: Byun, Hae-Ok, et al.
Publicado: (2015)

Impact of senescence‐associated secretory phenotype and its potential as a therapeutic target for senescence‐associated diseases
por: Watanabe, Sugiko, et al.
Publicado: (2017)

Cellular senescence and senescence‐associated secretory phenotype via the cGAS‐STING signaling pathway in cancer
por: Loo, Tze Mun, et al.
Publicado: (2019)

The impact of cellular senescence and senescence‑associated secretory phenotype in cancer‑associated fibroblasts on the malignancy of pancreatic cancer
por: Higashiguchi, Masaya, et al.
Publicado: (2023)

Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells
por: Cahu, J, et al.
Publicado: (2012)

Sensitive Detection and Monitoring of Senescence-Associated Secretory Phenotype by SASP-RAP Assay
por: Gu, Liubao, et al.
Publicado: (2012)

Small-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype
por: Wiley, Christopher D., et al.
Publicado: (2018)

Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy
por: Saleh, Tareq, et al.
Publicado: (2018)

Senescence-Associated Secretory Phenotype Determines Survival and Therapeutic Response in Cervical Cancer
por: Purohit, Sharad, et al.
Publicado: (2020)

Quantitative Proteomic Analysis of the Senescence‐Associated Secretory Phenotype by Data‐Independent Acquisition
por: Neri, Francesco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_96d715vla0h0904moimq551e3j